Business Description
SunWay Biotech Co Ltd
ISIN : TW0001271005
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.08 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.09 | |||||
Debt-to-EBITDA | 1.51 | |||||
Interest Coverage | 28.38 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 7 | |||||
Beneish M-Score | 2.47 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 24.6 | |||||
3-Year EBITDA Growth Rate | -15.3 | |||||
3-Year EPS without NRI Growth Rate | -27.7 | |||||
3-Year FCF Growth Rate | -61.4 | |||||
3-Year Book Growth Rate | 56.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 4.98 | |||||
9-Day RSI | 15.56 | |||||
14-Day RSI | 25.73 | |||||
6-1 Month Momentum % | -19.21 | |||||
12-1 Month Momentum % | 7.68 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.57 | |||||
Quick Ratio | 2.63 | |||||
Cash Ratio | 1.34 | |||||
Days Inventory | 147.59 | |||||
Days Sales Outstanding | 77.09 | |||||
Days Payable | 19.53 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.19 | |||||
Dividend Payout Ratio | 0.59 | |||||
Forward Dividend Yield % | 1.19 | |||||
5-Year Yield-on-Cost % | 1.19 | |||||
3-Year Average Share Buyback Ratio | -21.6 | |||||
Shareholder Yield % | -2.42 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 52.19 | |||||
Operating Margin % | 14.38 | |||||
Net Margin % | 12.28 | |||||
FCF Margin % | 1.6 | |||||
ROE % | 4.33 | |||||
ROA % | 3.66 | |||||
ROIC % | 4.25 | |||||
ROC (Joel Greenblatt) % | 19.79 | |||||
ROCE % | 4.81 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 50.18 | |||||
PE Ratio without NRI | 49.94 | |||||
Price-to-Owner-Earnings | 54.16 | |||||
PS Ratio | 5.08 | |||||
PB Ratio | 1.55 | |||||
Price-to-Tangible-Book | 5.76 | |||||
Price-to-Free-Cash-Flow | 848.48 | |||||
Price-to-Operating-Cash-Flow | 62.73 | |||||
EV-to-EBIT | 40.06 | |||||
EV-to-EBITDA | 25.69 | |||||
EV-to-Revenue | 6.06 | |||||
EV-to-FCF | 382.04 | |||||
Price-to-Graham-Number | 3.56 | |||||
Price-to-Net-Current-Asset-Value | 13.96 | |||||
Earnings Yield (Greenblatt) % | 2.49 | |||||
FCF Yield % | 0.26 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
SunWay Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 810.991 | ||
EPS (TTM) (NT$) | 1.674 | ||
Beta | 0 | ||
Volatility % | 56.61 | ||
14-Day RSI | 25.73 | ||
14-Day ATR (NT$) | 1.587834 | ||
20-Day SMA (NT$) | 88.175 | ||
12-1 Month Momentum % | 7.68 | ||
52-Week Range (NT$) | 81 - 145.5 | ||
Shares Outstanding (Mil) | 59.39 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
SunWay Biotech Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
SunWay Biotech Co Ltd Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
SunWay Biotech Co Ltd Frequently Asked Questions
What is SunWay Biotech Co Ltd(ROCO:1271)'s stock price today?
When is next earnings date of SunWay Biotech Co Ltd(ROCO:1271)?
Does SunWay Biotech Co Ltd(ROCO:1271) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |